In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking

Jiao-Long Wang, Liang Li, Mei-Bian Hu, Bo Wu, Wen-Xiang Fan, Wei Peng, Da-Neng Wei, Chun-Jie Wu. In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking. Computers & Chemistry, 78:297-305, 2019. [doi]

Abstract

Abstract is missing.